#weight-loss-drug

[ follow ]
from www.bbc.com
1 week ago

Nurse's death linked to approved weight-loss drug

The death of nurse Susan McGowan has raised concerns over the safety of the weight-loss drug Mounjaro, linked to her unexpected health decline.

BioAge Labs IPO: Stock price will be closely watched today as the obesity drug developer debuts on the Nasdaq

BioAge Labs is entering the public market with its obesity drug Azelaprag in clinical trials, aiming for significant growth and competition in the weight loss sector.
#eli-lilly

Here's how Eli Lilly is fixing its Zepbound supply shortage

Eli Lilly has begun selling starter doses of Zepbound in vials online to boost supply and accessibility.

Eli Lilly raises price of Zepbound while trumpeting discount on starter vials

Eli Lilly's Zepbound pricing strategy has both improved access with lower starter dosages while raising concerns over transparency with existing drug prices.

Zepbound shortage update: FDA issues 'limited availability' warning. When might it end?

Zepbound, a weight loss drug by Eli Lilly, facing shortage in certain doses in the U.S. due to increased demand.

Weight-Loss Drugs Help Sleep Apnea Symptoms

Zepbound, Eli Lilly's weight-loss drug, showed promising results in reducing breathing problems in patients with obstructive sleep apnea, potentially increasing insurance coverage.

Here's how Eli Lilly is fixing its Zepbound supply shortage

Eli Lilly has begun selling starter doses of Zepbound in vials online to boost supply and accessibility.

Eli Lilly raises price of Zepbound while trumpeting discount on starter vials

Eli Lilly's Zepbound pricing strategy has both improved access with lower starter dosages while raising concerns over transparency with existing drug prices.

Zepbound shortage update: FDA issues 'limited availability' warning. When might it end?

Zepbound, a weight loss drug by Eli Lilly, facing shortage in certain doses in the U.S. due to increased demand.

Weight-Loss Drugs Help Sleep Apnea Symptoms

Zepbound, Eli Lilly's weight-loss drug, showed promising results in reducing breathing problems in patients with obstructive sleep apnea, potentially increasing insurance coverage.
moreeli-lilly

Users of New Weight Loss Drug Had Lower Blood Pressure in Study

Tirzepatide, a weight loss drug, was found to significantly lower blood pressures after 36 weeks of use.
The study assessed tirzepatide's effects on weight loss and found that participants taking the drug had lower blood pressures when measured with a 24-hour monitor.

As Eli Lilly Wades Into Telehealth for Weight Loss, Doctors Are Wary

Eli Lilly has launched a new platform called LillyDirect to make it easier for patients to access its weight loss drug, Zepbound, by connecting them with telehealth providers and prescription delivery services.
The platform aims to ensure patients receive brand-name drugs and not counterfeit versions, as well as access coupons to lower the cost of the medication.

As Eli Lilly Wades Into Telehealth for Weight Loss, Doctors Are Wary

Eli Lilly has launched a new platform called LillyDirect to make it easier for patients to access its weight loss drug, Zepbound, by connecting them with telehealth providers and prescription delivery services.
The platform aims to ensure patients receive brand-name drugs and not counterfeit versions, as well as access coupons to lower the cost of the medication.

As Eli Lilly Wades Into Telehealth for Weight Loss, Doctors Are Wary

Eli Lilly has launched a new platform called LillyDirect to make it easier for patients to access its weight loss drug, Zepbound, by connecting them with telehealth providers and prescription delivery services.
The platform aims to ensure patients receive brand-name drugs and not counterfeit versions, as well as access coupons to lower the cost of the medication.
#off-label-us

Weight loss has changed: Ozempic, intermittent fasting and new ways to shed pounds in 2024

Weight loss drugs like Ozempic and Wegovy are being used off-label for rapid weight loss.
Florida is experiencing an influx of weight loss clinics, med spas, and online pharmacies selling these drugs.

Weight loss has changed: Ozempic, intermittent fasting and new ways to shed pounds in 2024

Weight loss drugs like Ozempic and Wegovy are being used off-label for rapid weight loss.
Florida is experiencing an influx of weight loss clinics, med spas, and online pharmacies selling these drugs.

Weight loss has changed: Ozempic, intermittent fasting and new ways to shed pounds in 2024

Weight loss drugs like Ozempic and Wegovy are being used off-label for rapid weight loss.
Florida is experiencing an influx of weight loss clinics, med spas, and online pharmacies selling these drugs.

Weight loss has changed: Ozempic, intermittent fasting and new ways to shed pounds in 2024

Weight loss drugs like Ozempic and Wegovy are being used off-label for rapid weight loss.
Florida is experiencing an influx of weight loss clinics, med spas, and online pharmacies selling these drugs.
moreoff-label-us

Weight loss has changed: Ozempic, intermittent fasting and new ways to shed pounds in 2024

Weight loss drugs like Ozempic and Wegovy are being used off-label for rapid weight loss.
Florida is experiencing an influx of weight loss clinics, med spas, and online pharmacies selling these drugs.
#obes

The Guardian view on anti-obesity drugs: treating a disease that modernity made | Editorial

Obesity is not solely due to personal character, but also influenced by modern factors like sedentary work and processed foods.
Weight-loss drugs like Wegovy are expensive, raising questions about access and healthcare priorities.

5 Ways Ozempic and Other New Weight-Loss Drugs Have Changed Health

New classes of weight-loss drugs are changing the way we think and talk about weight, dieting, and obesity.
These weight-loss drugs offer fast and easy weight loss and unexpected cardiac benefits, but high costs and poor accessibility pose challenges.

The Guardian view on anti-obesity drugs: treating a disease that modernity made | Editorial

Obesity is not solely due to personal character, but also influenced by modern factors like sedentary work and processed foods.
Weight-loss drugs like Wegovy are expensive, raising questions about access and healthcare priorities.

5 Ways Ozempic and Other New Weight-Loss Drugs Have Changed Health

New classes of weight-loss drugs are changing the way we think and talk about weight, dieting, and obesity.
These weight-loss drugs offer fast and easy weight loss and unexpected cardiac benefits, but high costs and poor accessibility pose challenges.
moreobes

How Much Weight Comes Back After Stopping a Weight-Loss Drug?

New research confirms that people may have to stay on the weight loss drug Zepbound for the rest of their lives to keep the weight off.
Participants who continued taking tirzepatide, the compound in Zepbound, lost more weight compared to those who switched to a placebo.

How Much Weight Comes Back After Stopping a Weight-Loss Drug?

New research confirms that people may have to stay on the weight loss drug Zepbound for the rest of their lives to keep the weight off.
Participants who continued taking tirzepatide, the compound in Zepbound, lost more weight compared to those who switched to a placebo.

How Much Weight Comes Back After Stopping a Weight-Loss Drug?

New research confirms that people may have to stay on the weight loss drug Zepbound for the rest of their lives to keep the weight off.
Participants who continued taking tirzepatide, the compound in Zepbound, lost more weight compared to those who switched to a placebo.

How Much Weight Comes Back After Stopping a Weight-Loss Drug?

New research confirms that people may have to stay on the weight loss drug Zepbound for the rest of their lives to keep the weight off.
Participants who continued taking tirzepatide, the compound in Zepbound, lost more weight compared to those who switched to a placebo.

How Much Weight Comes Back After Stopping a Weight-Loss Drug?

New research confirms that people may have to stay on the weight loss drug Zepbound for the rest of their lives to keep the weight off.
Participants who continued taking tirzepatide, the compound in Zepbound, lost more weight compared to those who switched to a placebo.
#semaglutide

Weight Loss Drug Wegovy Can Also Reduce Risk of Serious Heart Events, Study Shows

The weight loss drug semaglutide, sold under brand names Wegovy, Ozempic, and Rybelsus, has been found to reduce the risk of dying from heart disease in some patients.
A study involving over 17,000 people without diabetes but with a history of heart issues showed that those who received semaglutide lost about 9% of their body weight and reduced their risk of heart attack, stroke, or death from a heart event by 20%.
The results of the study were presented at the American Heart Association meeting and published in the New England Journal of Medicine.

Weight Loss Drug Wegovy Can Also Reduce Risk of Serious Heart Events, Study Shows

The weight loss drug semaglutide, sold under brand names Wegovy, Ozempic, and Rybelsus, has been found to reduce the risk of dying from heart disease in some patients.
A study involving over 17,000 people without diabetes but with a history of heart issues showed that those who received semaglutide lost about 9% of their body weight and reduced their risk of heart attack, stroke, or death from a heart event by 20%.
The results of the study were presented at the American Heart Association meeting and published in the New England Journal of Medicine.

Weight Loss Drug Wegovy Can Also Reduce Risk of Serious Heart Events, Study Shows

The weight loss drug semaglutide, sold under brand names Wegovy, Ozempic, and Rybelsus, has been found to reduce the risk of dying from heart disease in some patients.
A study involving over 17,000 people without diabetes but with a history of heart issues showed that those who received semaglutide lost about 9% of their body weight and reduced their risk of heart attack, stroke, or death from a heart event by 20%.
The results of the study were presented at the American Heart Association meeting and published in the New England Journal of Medicine.

Weight Loss Drug Wegovy Can Also Reduce Risk of Serious Heart Events, Study Shows

The weight loss drug semaglutide, sold under brand names Wegovy, Ozempic, and Rybelsus, has been found to reduce the risk of dying from heart disease in some patients.
A study involving over 17,000 people without diabetes but with a history of heart issues showed that those who received semaglutide lost about 9% of their body weight and reduced their risk of heart attack, stroke, or death from a heart event by 20%.
The results of the study were presented at the American Heart Association meeting and published in the New England Journal of Medicine.

Weight Loss Drug Wegovy Can Also Reduce Risk of Serious Heart Events, Study Shows

The weight loss drug semaglutide, sold under brand names Wegovy, Ozempic, and Rybelsus, has been found to reduce the risk of dying from heart disease in some patients.
A study involving over 17,000 people without diabetes but with a history of heart issues showed that those who received semaglutide lost about 9% of their body weight and reduced their risk of heart attack, stroke, or death from a heart event by 20%.
The results of the study were presented at the American Heart Association meeting and published in the New England Journal of Medicine.

Weight Loss Drug Wegovy Can Also Reduce Risk of Serious Heart Events, Study Shows

The weight loss drug semaglutide, sold under brand names Wegovy, Ozempic, and Rybelsus, has been found to reduce the risk of dying from heart disease in some patients.
A study involving over 17,000 people without diabetes but with a history of heart issues showed that those who received semaglutide lost about 9% of their body weight and reduced their risk of heart attack, stroke, or death from a heart event by 20%.
The results of the study were presented at the American Heart Association meeting and published in the New England Journal of Medicine.
moresemaglutide
[ Load more ]